Oncolytic reovirus induces intracellular redistribution of Ras to promote apoptosis and progeny virus release

Oncogene

Volumn 35, Issue 6, 2016, Pages 771-782

  Garant, K A ^a   Shmulevitz, M ^b   Pan, L ^c   Daigle, R M ^d   Ahn, D G ^a   Gujar, S A ^a,e   Lee, P W K ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e IWK HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 BROMOPALMITIC ACID; CD8ALPHA RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; PALMITIC ACID; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; ONCOLYTIC VIRUS; PROTEIN P21;

3T3 CELL LINE; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL COUNT; CELL FRACTIONATION; CELL MEMBRANE; CELL TRANSFORMATION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE ACTIVITY; GENE EXPRESSION; GENE LOCATION; GENE STRUCTURE; GENETIC ANALYSIS; GOLGI COMPLEX; HUMAN; HUMAN CELL; L929 CELL LINE; LIFE CYCLE; MOLECULAR SIZE; MOUSE; NONHUMAN; ONCOGENE H RAS; ONCOGENE RAS; ONCOLYTIC VIROTHERAPY; PALMITOYLATION; PRIORITY JOURNAL; REOVIRIDAE; REOVIRUS INFECTION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS ASSEMBLY; VIRUS RELEASE; ANIMAL; CELL CULTURE; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT; VIRUS REPLICATION;

ANIMALS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; HEK293 CELLS; HUMANS; MICE; NIH 3T3 CELLS; ONCOGENE PROTEIN P21(RAS); ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; PROTEIN TRANSPORT; REOVIRIDAE; SIGNAL TRANSDUCTION; VIRUS RELEASE; VIRUS REPLICATION;

EID: 84958035584     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.136     Document Type: Article

References (49)

1. Coffey MC, Strong JE, Forsyth PA, Lee PWK. Reovirus therapy of tumors with activated Ras pathway. Science 1998; 282: 1332-1334.
2. Strong JE, Coffey MC, Tang D, Sabinin P, Lee PWK. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J 1998; 17: 3351-3362.
3. Calvo F, Agudo-Ibáñez L, Crespo P. The Ras-ERK pathway: understanding sitespecific signaling provides hope of new anti-tumor therapies. BioEssays 2010; 32: 412-421.
4. Norman KL, Coffey MC, Hirasawa K, Demetrick DJ, Nishikawa SG, DiFrancesco LM et al. Reovirus oncolysis of human breast cancer. Hum Gene Ther 2002; 13: 641-652.
5. Hirasawa K, Nishikawa S, Norman K, Alain T, Kossakowska A, Lee PWK. Oncolytic reovirus against ovarian and colon cancer. Cancer Res 2002; 62: 1696-1701.
6. Oncolytics Biotech Inc Reovirus clinical trials, 2014. Available at: http://www. oncolyticsbiotech.com/clinical-trials/default.aspx (last accessed 13 April 2015).
7. Marcato P, Shmulevitz M, Pan D, Stoltz D, Lee PWK. Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release. Mol Ther 2007; 15: 1522-1530.
8. Shmulevitz M, Pan L, Garant K, Pan D, Lee PWK. Oncogenic Ras promotes reovirus spread by suppressing IFN-beta production through negative regulation of RIG-I signaling. Cancer Res 2010; 70: 4912-4921.
9. Der CJ, Krontiris TG, Cooper GM. Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci USA 1982; 79: 3637-3640.
10. Shimizu K, Goldfarb M, Perucho M, Wigler M. Isolation and preliminary characterization of the transforming gene of a human neuroblastoma cell line. Proc Natl Acad Sci 1983; 80: 383-387.
11. Ahearn IM, Haigis K, Bar-Sagi D, Philips MR. Regulating the regulator: posttranslational modification of RAS. Nat Rev Mol Cell Biol 2012; 13: 39-51.
12. Casey PJ, Solski PA, Der CJ, Buss JE. P21ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci USA 1989; 86: 8323-8327.
13. Boyartchuk VL, Ashby MN, Rine J. Modulation of ras and a-factor function by carboxyl-terminal proteolysis. Science 1997; 275: 1796-1800.
14. Dai Q, Choy E, Chiu V, Romano J, Slivka SR, Steitz SA et al. Mammalian prenylcysteine carboxyl methyltransferase is in the endoplasmic reticulum. J Biol Chem 1998; 273: 15030-15034.
15. Choy E, Chiu VK, Silletti J, Feoktistov M, Morimoto T, Michaelson D et al. Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Cell 1999; 98: 69-80.
16. Hancock JF, Magee AI, Childs JE, Marshall J. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 1989; 57: 1167-1177.
17. Swarthout JT, Lobo S, Farh L, Croke MR, Greentree WK, Deschenes RJ et al. DHHC9 and GCP16 constitute a human protein fatty acyltransferase with specificity for H-and N-ras. J Biol Chem 2005; 280: 31141-31148.
18. Shahinian S, Silvius JR. Doubly-lipid-modified protein sequence motifs exhibit long-lived anchorage to lipid bilayer membranes. Biochemistry 1995; 34: 3813-3822.
19. Ahearn IM, Tsai FD, Court H, Zhou M, Jennings BC, Ahmed M et al. FKBP12 binds to acylated H-Ras and promotes depalmitoylation. Mol Cell 2011; 41: 173-185.
20. Duncan J, Gilman A. A cytoplasmic acyl-protein thioesterase that removes palmitate from G protein alpha subunits and p21RAS. J Biol Chem 1998; 273: 15830-15837.
21. Rocks O, Peyker A, Kahms M, Verveer PJ, Koerner C, Lumbierres M et al. An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science 2005; 307: 1746-1752.
22. Goodwin JS, Drake KR, Rogers C, Wright L, Lippincott-Schwartz J, Philips MR et al. Depalmitoylated Ras traffics to and from the Golgi complex via a nonvesicular pathway. J Cell Biol 2005; 170: 261-272.
23. Roy S, Plowman S, Rotblat B, Prior IA, Muncke C, Grainger S et al. Individual palmitoyl residues serve distinct roles in H-Ras. Mol Cell Biol 2005; 25: 6722-6733.
24. Chiu VK, Bivona T, Hach A, Sajous JB, Silletti J, Wiener H et al. Ras signalling on the endoplasmic reticulum and the Golgi. Nat Cell Biol 2002; 4: 343-350.
25. Matallanas D, Sanz-Moreno V, Arozarena I, Calvo F, Agudo-Ibáñez L, Santos E et al. Distinct utilization of effectors and biological outcomes resulting from site-specific ras activation : Ras functions in lipid rafts and golgi complex are dispensable for proliferation and transformation. Mol Cell Biol 2006; 26: 100-116.
26. Bos JL. Ras oncogenes in human cancer : a review. Cancer Res 1989; 49: 4682-4689.
27. Vigil D, Cherfils J, Rossman K, Der C. Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? Nat Rev Cancer 2010; 10: 842-857.
28. Gutierrez L, Magee AI, Marshall CJ, Hancock JF. Post-translational processing of p21ras is two-step and involves carboxyl-methylation and carboxy-terminal proteolysis. EMBO J 1989; 8: 1093-1098.
29. Stickney BJT, Booden MA, Buss JE. Targeting proteins to membranes, using signal sequences for lipid modifications. Methods Enzymol 2001; 332: 64-77.
30. Drisdel RC, Alexander JK, Sayeed A, Green WN. Assays of protein palmitoylation. Methods 2006; 40: 127-134.
31. Colanzi A, Suetterlin C, Malhotra V. Cell-cycle-specific Golgi fragmentation: how and why? Curr Opin Cell Biol 2003; 15: 462-467.
32. Mukherjee S, Chiu R, Leung S-M, Shields D. Fragmentation of the Golgi apparatus: an early apoptotic event independent of the cytoskeleton. Traffic 2007; 8: 369-378.
33. Nozawa K, Casiano CA, Hamel JC, Molinaro C, Fritzler MJ, Chan EKL. Fragmentation of Golgi complex and Golgi autoantigens during apoptosis and necrosis. Arthritis Res 2002; 4: R3.
34. Parker JSL, Broering TJ, Kim J, Higgins E, Nibert ML. Reovirus core protein ?2 determines the filamentous morphology of viral inclusion bodies by interacting with and stabilizing microtubules. J Virol 2002; 76: 4483-4496.
35. Sharpe AH, Chen LB, Fields BN. The interaction of mammalian reoviruses with the cytoskeleton of monkey kidney CV-1 cells. Virology 1982; 120: 399-411.
36. Resh MD. Use of analogs and inhibitors to study the functional significance of protein palmitoylation. Methods 2006; 40: 191-197.
37. Webb Y, Hermida-Matsumoto L, Resh MD. Inhibition of protein palmitoylation, raft localization, and T cell signaling by 2-bromopalmitate and polyunsaturated fatty acids. J Biol Chem 2000; 275: 261-270.
38. Clarke P, Meintzer S, Wang Y. JNK regulates the release of proapoptotic mitochondrial factors in reovirus-infected cells. J Virol 2004; 78: 13132-13138.
39. Russell M, Lange-Carter C, Johnson G. Direct interaction between Ras and the kinase domain of mitogen-activated protein kinase kinase kinase (MEKK1). J Biol Chem 1995; 270: 11757-11760.
40. Kominsky DJ, Bickel RJ, Tyler KL. Reovirus-induced apoptosis requires both death receptor-and mitochondrial-mediated caspase-dependent pathways of cell death. Cell Death Differ 2002; 9: 926-933.
41. Kominsky D, Bickel R, Tyler K. Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels. J Virol 2002; 76: 11414-11424.
42. Ilkow CS, Swift SL, Bell JC, Diallo J-S. From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer. PLoS Pathogen 2014; 10: e1003836.
43. Avitabile E, Di Gaeta S, Torrisi MR, Ward PL, Roizman B, Campadelli-Fiume G. Redistribution of microtubules and Golgi apparatus in herpes simplex virusinfected cells and their role in viral exocytosis. J Virol 1995; 69: 7472-7482.
44. Summy JM, Gallick GE. Src family kinases in tumor progression and metastasis. Cancer Metast Rev 2003; 22: 337-358.
45. Grabocka E, Pylayeva-Gupta Y, Jones MJK, Lubkov V, Yemanaberhan E, Taylor L et al. Wild-type H-and N-Ras promote mutant K-Ras-driven tumorigenesis by modulating the DNA damage response. Cancer Cell 2014; 25: 243-256.
46. Heinemann L, Simpson GR, Boxall A, Kottke T, Relph KL, Vile R et al. Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer. BMC Cancer 2011; 11: 221.
47. Baines A, Xu D, Der C. Inhibition of Ras for cancer treatment: the search continues. Fut Med Chem 2011; 3: 1787-1808.
48. Mendez II, Hermann LL, Hazelton PR, Coombs KM. A comparative analysis of Freon substitutes in the purification of reovirus and calicivirus. J Virol Methods 2000; 90: 59-67.
49. Dekker FJ, Rocks O, Vartak N, Menninger S, Hedberg C, Balamurugan R et al. Small-molecule inhibition of APT1 affects Ras localization and signaling. Nat Chem Biol 2010; 6: 449-456.